Hefei Lifeon Pharmaceutical (003020.SZ) Methorphan Hydrochloride raw material drug listing application accepted

Hefei Lifeon Pharmaceutical (003020.SZ) announced that the company has received the "Notice of Acceptance" for the application for the listing of methylphenidate hydrochloride raw materials issued by the National Medical Products Administration. Methylphenidate hydrochloride is a central nervous system stimulant used for the treatment of attention deficit hyperactivity disorder (ADHD).